Jeffrey Smoot

Information Scientist, CAS

Bio

Jeffrey Smoot has been an information scientist at CAS for 30 years. Prior to joining CAS, Jeffrey held a research position with Northwestern University and was a Hematology-Oncology Fellow at The Ohio State University. He obtained a B.A. in chemistry and a B.S. in biology from the University of California, Irvine and a PhD. in Biochemistry from The Ohio State University.

Drug Discovery
Preliminary study of the Omicron variant indicates that it has evolved significantly from the original version of the virus first identified in China in 2019, which means there is an increased likelihood that it could reinfect those who have already had COVID-19 or evade the immunity generated by the current first generation of vaccines. Such a variant could drastically set back the global pandemic recovery, resulting in staggering societal and economic impacts.
November 30, 2021|Article